2020 Peripheral Nerve Injuries Market - Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peripheral Nerve Injuries - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the PNI, historical and forecasted epidemiology as well as the PNI market trends in the United States, EU5(Germany, France, Italy, Spain, and the United Kingdom) and Japan.

The PNI market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM PNI market size from 2017 to 2030. The report also covers current PNI treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

To fully determine the extent of the damage to the nerve, an electrical conduction test can be used to determine the passage of electrical currents through the nerves. The tests used for diagnosis include electromyography (EMG), nerve conduction velocity (NCV) test, MRI neurography, CT scan, and biopsy. Different tests like blood tests, spinal fluid tests, muscle strength tests, and tests of the ability to detect vibrations can also be performed.

Depending on the location and degree of the nerve damage, the doctor may prescribe different courses of therapy. For mild nerve injuries, the following non-surgical treatments may be part of the plan such as acupuncture, massage therapy, medication, orthotics, physical therapy and rehabilitation, and weight loss. More severe injuries may require peripheral nerve surgery, which is performed by a neurosurgeon. These surgical procedures can be highly complicated, and this is why it is essential to select an experienced surgeon and team for peripheral nerve operations which may involve nerve grafting, nerve regeneration, or tendon or muscle transfer.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Number of Annual Peripheral Nerve Injuries, Total Annual Number of PNI by Extremities and Total Number of PNI Surgeries Performed scenario of PNI in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2017 to 2030.

Key Findings

This section provides glimpses of the PNI epidemiology in the 7MM.

• The total number of Annual PNI cases in the 7MM was 3,889,176 in 2017.
• The United States accounted for the highest number of PNI cases among the 7MM. The total number of PNI cases in the US was estimated to be 1,645,218 in 2017.
• Upper extremities and lower extremities PNI cases in the US were 1,151,901 and 493,316, respectively in 2017.
• The total number of surgeries performed for PNI in the US was estimated to be 720,605 in 2017.
• Among the European 5 countries, Italy had the highest cases of PNI with 412,612 cases, followed by France and the United Kingdom with 292,295 cases, and 276,320 cases, respectively. On the other hand, Spain had the lowest cases, i.e., 142,880 in 2017.
• Japan ranks second highest for numbers of PNI cases among 7MM. In 2017, there were an estimated 848,800 cases of PNI in Japan.

Country Wise-PNI Epidemiology

The epidemiology segment also provides the PNI epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Key Findings

This section includes a glimpse of the PNI 7MM market.

• The market size of PNI in the seven major markets was USD 2,182.82 million in 2017.
• The market size of Peripheral Nerve Injuries (PNI) in the US was USD 1,396.92 million in 2017.
• Among the EU-5 countries, Italy has the highest market size followed by France and the UK. The lowest market size was estimated in Spain with USD 54.03 million in 2017.
• The current management of PNI includes the use of sutures, nerve conduits & processed nerve allograft, and autograft. For small injured nerves in which small area of nerve is damaged, sutures are performed that joins the broken and affected nerve. There are many Food and Drug Administration (FDA) and EMA approved collagen-based conduits such as NeuraGen, NeuroFlex, NeuroMatrix, NeuroWrap, NeuroMend, and several others. Apart from these, an allograft, i.e., Avance Nerve Graft is also present in the market.
• The market size of Autograft, and nerve conduits & processed nerve allografts was estimated to be USD 1,560.95 million, and USD 583.81 million, respectively in 2017, in the 7MM.
• CelGro and NTX-001 are expected to enter the US market in 2021 and 2023, and EU-5 and Japan market in 2022, and 2024, respectively.

Companies Mentioned

• Toyobo
• Polyganics
• Axogen Corporation
• Neuraptive Therapeutics
• Silk Biomaterials
• Orthocell Limited

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/ol64vg